The final guidance, published last week, recommends that patients should be offered pra-sugrel in combination with aspirin if they require treatment for ST-segment-elevation MI.
They should also receive the treatment if they have devel-oped a blood clot blocking a stent while receiving treatment with clopidogrel.
Diabetic patients should also be considered for the combination treatment, NICE has recommended.
Dr Carole Longson, director of NICE's Health Technology Evaluation Centre, said: 'There are a range of heart problems classed as acute coronary syndromes - these have a huge impact on the individuals affected.
'This new guidance recom-mending prasugrel in combina-tion with aspirin will offer an additional treatment option for these specific individuals at risk of blood clots,' Dr Longson added.